influenza
viru
iav
often
caus
extens
respiratori
infect
sever
iav
infect
usual
lead
acut
lung
injuri
ali
acut
respiratori
distress
syndrom
ard
aliard
one
main
caus
death
intens
care
unit
icu
high
mortal
rate
current
specif
medicin
avail
manag
aliard
infect
iav
hijack
array
intracellular
signal
cascad
benefit
tlr
rigi
pkcpkr
mapk
signal
pathway
iav
infect
increas
express
phosphoryl
akt
mapk
nuclear
transloc
sever
iavinfect
die
patient
lastingli
highli
express
report
last
activ
detriment
iavinduc
acut
pneumonia
convers
iavinfect
mice
unexpect
surviv
advantag
significantli
lower
viral
titer
less
inflammatori
mediat
fewer
patholog
chang
lung
report
markedli
cluster
site
iavcel
interact
cytomembran
determin
iav
entri
tissu
tropism
express
mapk
activ
inactiv
avian
influenza
viru
induc
sever
oxid
stress
rapidli
lead
ali
signal
mice
report
highli
refractori
iavinduc
ali
antagonist
eritoran
decreas
viral
titer
iavinduc
lethal
activ
also
necessari
effici
replic
iav
sever
inhibitor
signal
effect
suppress
iav
replic
iavinduc
upregul
proinflammatori
cytokin
matrix
metalloproteinas
mmp
moreov
activ
signal
also
essenti
releas
neutrophil
excess
migrat
two
princip
caus
aliard
addit
downstream
cascad
tlr
mapk
pathway
also
requir
iav
infect
prolifer
base
fact
iavinduc
overexpress
tlr
trif
abnorm
nuclear
transloc
essenti
iav
infect
construct
seri
luciferas
report
plasmid
base
promot
gene
nuclear
respons
element
use
plasmid
perform
sever
time
drug
screen
assay
found
sophora
root
sophora
flavescen
aiton
tradit
herbal
medicin
use
antipyret
diuret
anthelmint
agent
china
thousand
year
significantli
inhibit
pathway
oxymatrin
omt
major
activ
compound
sophora
root
report
omt
antioxid
antiinflamm
antiviru
hepatoprotect
immunosuppress
activ
current
extens
employ
treat
viral
hepat
traumat
brain
injuri
acut
pancreat
sepsi
ali
clinic
previou
studi
found
omt
low
concentr
inhibit
iav
infect
vitro
vivo
present
studi
determin
effect
omt
iav
infect
high
concentr
vitro
vivo
investig
mechan
action
omt
mainli
focus
tlr
mapk
signal
pathway
experiment
determin
cytotox
omt
mdck
cell
result
show
omt
significantli
reduc
viabil
cell
concentr
x
figur
cytotox
omt
mdck
similar
cell
figur
plaqu
inhibit
assay
found
omt
could
significantli
inhibit
iav
replic
rang
figur
c
x
ai
chose
test
concentr
follow
pharmacolog
experi
besid
omt
also
could
significantli
inhibit
infect
determin
sulforhodamin
b
srb
method
respect
figur
moreov
omt
also
could
significantli
inhibit
infect
differ
multipl
infect
moi
figur
final
detect
effect
omt
viru
life
cycl
ie
step
iav
replic
inhibit
perform
timeofaddit
assay
found
omt
could
directli
inactiv
iav
signific
influenc
cell
iav
infect
iav
adsorpt
inhibit
omt
iav
replic
occur
h
post
infect
pi
figur
detect
influenc
omt
activ
tlr
signal
pathway
first
construct
promot
luciferas
report
human
trif
gene
shown
figur
without
iav
infect
omt
alon
could
significantli
decreas
promot
activ
gene
iav
infect
omt
also
could
significantli
decreas
iavinduc
upregul
promot
activ
gene
addit
result
western
blot
assay
also
show
omt
could
significantli
decreas
iavinduc
high
express
gene
cell
figur
report
iavinduc
activ
rafmekerk
jnk
mapk
signal
pathway
support
iav
infect
addit
also
report
omt
inhibit
activ
pathway
brain
damag
cirrhot
rat
lpsstimul
microgli
cell
therefor
also
determin
effect
omt
iavinfect
cell
signal
pathway
show
figur
b
omt
could
significantli
inhibit
iavinduc
phosphoryl
akt
mapk
nuclear
transloc
significantli
iavinduc
phosphoryl
jnk
investig
western
blot
assay
addit
detect
influenc
omt
transcript
downstream
target
gene
purchas
report
plasmid
duplic
respons
element
gggaatttcc
beyotim
institut
biotechnolog
shanghai
china
show
figur
omt
could
significantli
inhibit
transcript
report
plasmid
matter
iav
infect
determin
import
tlr
signal
pathway
antiiav
activ
omt
activ
signal
pathway
use
result
show
activ
mapk
activ
anisomycin
activ
pma
could
significantli
antagon
inhibitori
effect
omt
iavinduc
decreas
cell
viabil
determin
srb
method
significantli
counteract
inhibitori
effect
omt
iav
replic
determin
qrtpcr
assay
effect
activ
polyi
c
activ
activ
activ
egf
signific
figur
iav
infect
induc
product
inflammatori
cytokin
high
level
inflammatori
cytokin
report
contribut
sever
pulmonari
histopatholog
chang
iav
infect
studi
also
determin
influenc
omt
iavmedi
releas
elisa
assay
shown
figur
omt
could
significantli
inhibit
releas
iav
infect
iav
infect
day
mice
start
show
diseas
symptom
ruffl
fur
follow
labor
breath
loss
bodi
weight
day
pi
oseltamivir
mgkgday
pc
omt
mgkgday
treatment
could
significantli
increas
bodi
weight
mice
infect
iav
respect
figur
day
pi
surviv
rate
group
nc
oseltamivir
pc
omt
mgkgday
mgkgday
treat
group
respect
oseltamivir
omt
could
significantli
increas
surviv
rate
mice
infect
iav
figur
addit
omt
oseltamivir
could
significantli
reduc
lung
index
transcript
figur
significantli
reduc
pulmonari
viral
load
determin
day
pi
figur
f
addit
compar
mgkgday
omttreat
group
omt
mgkgday
could
reduc
lung
index
viral
titer
though
significantli
figur
f
qrtpcr
assay
iav
vrna
level
significantli
decreas
mgkgday
omttreat
group
figur
furthermor
compar
oseltamivir
mgkgday
omt
significantli
less
inhibitori
effect
lung
index
viral
titer
final
histopatholog
chang
assay
lung
nc
group
show
signific
alveolar
exud
thicken
destruct
alveolar
wall
alveolar
hemorrhag
red
blood
cell
within
alveolar
space
oseltamivir
omt
could
significantli
inhibit
histopatholog
chang
induc
iav
infect
observ
day
pi
figur
fight
iav
infect
tradit
chines
medicin
tcm
play
import
role
swine
flu
outbreak
chines
govern
releas
document
entitl
recommend
scheme
pandem
influenza
diagnos
treatment
recommend
four
antiflu
tcm
prescript
chines
nation
health
famili
plan
commiss
also
releas
relat
document
diagnos
treatment
flu
respect
separ
recommend
five
tcm
prescript
past
decad
alway
devot
research
antiiav
drug
screen
tcm
recent
construct
seri
luciferas
report
plasmid
base
gene
promot
signal
pathway
screen
sever
tcm
excel
antiiav
activ
sophora
root
one
investig
previou
research
relat
literatur
find
sophora
root
major
activ
compound
omt
use
treatment
chronic
viral
hepat
clinic
mani
year
moreov
pandem
sever
acut
respiratori
syndrom
sar
chines
bureau
scienc
technolog
announc
composit
sophora
japonica
inject
mainli
contain
omt
distinct
effect
treatment
sar
display
magic
power
omt
treat
system
inflammatori
respons
specul
omt
inhibit
iav
infect
may
directli
util
fight
iav
clinic
initi
expect
omt
realli
inhibit
replic
iav
includ
vitro
vivo
among
belong
human
iav
belong
avian
influenza
viru
explor
mechan
action
omt
iav
infect
although
tlr
signal
pathway
play
import
role
innat
immun
viru
infect
activ
signal
pathway
report
requir
iav
prolifer
last
activ
tlr
pathway
even
support
iav
replic
detriment
iavinduc
acut
pneumonia
present
studi
find
omt
significantli
decreas
express
gene
iav
infect
preliminarili
specul
omt
may
inhibit
iav
prolifer
iav
viral
pneumonia
via
inhibit
tlr
signal
pathway
activ
downstream
cascad
tlr
signal
pathway
mapk
also
report
essenti
iav
infect
report
activ
pathway
support
iav
infect
inhibit
akt
suppress
iav
entri
iav
rnp
nuclear
export
pleschka
et
al
show
activ
rafmekerk
signal
prerequisit
iav
replic
blockad
erk
pathway
retard
rnp
export
reduc
viru
titer
marjuki
h
et
al
show
iavinduc
activ
erk
requir
fusion
iav
viral
particl
target
cell
mediat
vatpasedepend
intracellular
ph
chang
guo
b
et
al
show
mapk
key
determin
viru
entri
tissu
tropism
activ
signal
also
prerequisit
iav
infect
inhibitor
specif
diminish
iav
vrna
transcript
crna
promot
reduc
vrna
synthesi
result
shown
omt
significantli
decreas
iavinduc
activ
akt
mapk
pathway
may
impli
signal
pathway
may
also
implic
antiiav
activ
omt
determin
import
signal
pathway
antiiav
activ
omt
activ
signal
pathway
use
present
studi
result
show
mapk
activ
significantli
counteract
antiiav
activ
omt
includ
iavinduc
cpe
iav
replic
activ
show
figur
think
omtinhibit
iav
replic
may
inhibit
mapk
signal
pathway
aforement
pathway
prove
essenti
iav
replic
iav
infect
also
induc
abnorm
elev
express
inflammatori
cytokin
mmp
report
contribut
sever
lung
injuri
also
promot
iav
prolifer
respiratori
tract
omt
wellknown
strong
immunosuppress
agent
determin
effect
omt
express
inflammatori
cytokin
mmp
find
omt
significantli
suppress
iavinduc
releas
moreov
report
iavinduc
releas
mapk
specul
inhibit
omt
iavinduc
product
inflammatori
cytokin
may
least
part
via
inhibit
mapk
pathway
fact
report
omt
inhibit
activ
pathway
reduc
releas
inflammatori
mediat
fan
hg
et
al
report
omt
protect
brain
damag
downregul
pathway
wen
jb
et
al
indic
omt
improv
intestin
epitheli
barrier
function
inhibit
signal
pathway
cirrhot
rat
dong
xq
et
al
report
omt
inhibit
phosphoryl
erk
jnk
mapk
suppress
nuclear
transloc
decreas
mrna
product
ino
final
inhibit
product
lpsstimul
microgli
cell
dosedepend
manner
final
vivo
test
show
omt
inhibit
iavinduc
loss
bodi
weight
increas
surviv
rate
decreas
pulmonari
edema
transcript
inflammatori
cytokin
pulmonari
viral
load
improv
histopatholog
chang
fact
previou
studi
determin
effect
omt
iav
infect
lower
concentr
find
omt
inhibit
iav
infect
vitro
vivo
carri
present
studi
higher
concentr
vitro
vivo
addit
omt
also
report
abl
attenu
oleic
acid
induc
ali
mice
cecal
ligat
punctureinduc
septic
shock
rat
show
omt
possess
excel
activ
inhibit
system
inflammatori
respons
addit
antiinflammatori
drug
divid
steroid
nonsteroid
antiinflammatori
drug
highdos
steroid
antiinflammatori
drug
usual
employ
treat
aliard
often
caus
seriou
side
effect
osteoporosi
vascular
necrosi
omt
exert
antiinflammatori
effect
independ
pituitaryadren
system
specul
omt
may
advantag
treat
aliard
steroid
antiinflammatori
drug
oxymatrin
omt
puriti
purchas
nation
institut
control
pharmaceut
biolog
product
beij
china
mtt
tpcktrypsin
ribavirin
sulforhodamin
b
srb
purchas
sigmaaldrich
inc
st
loui
mo
usa
minimum
essenti
medium
mem
lipofectamin
reagent
pfu
dna
polymeras
dnase
trizol
reagent
purchas
invitrogen
life
technolog
inc
carlsbad
ca
usa
luciferas
report
assay
kit
bought
bd
bioscienc
clontech
franklin
lake
nj
usa
poli
c
tlrlpic
pma
tlrlpma
purchas
invivogen
san
diego
ca
usa
egf
anisomycin
antipakt
antiakt
antipjnk
antijnk
antibodi
bought
cell
signal
inc
compani
danver
usa
antilamin
secondari
horseradish
peroxidaseconjug
antirabbit
antimous
antibodi
purchas
santa
cruz
biotechnolog
santa
cruz
ca
usa
ecl
plu
western
blot
substrat
purchas
thermo
fisher
cleveland
oh
usa
chemic
solvent
commerci
avail
analyt
grade
viru
stock
iav
strain
prepar
mdck
cell
embryon
egg
viru
titer
determin
plaqu
format
assay
cytotox
omt
mdck
cell
determin
mtt
assay
concentr
omt
requir
lower
cell
viabil
calcul
use
origin
softwar
experi
iav
perform
biosafeti
level
laboratori
construct
promot
luciferas
report
plasmid
human
trif
gene
human
promot
promot
promot
promot
promot
promot
promot
trif
promot
promot
amplifi
pfu
dna
polymeras
invitrogen
use
cell
genom
dna
templat
pcr
product
clone
vector
name
ptrifluc
respect
primer
present
tabl
construct
verifi
doubl
enzym
digest
figur
dna
sequenc
assay
report
plasmid
purchas
beyotim
institut
biotechnolog
shanghai
china
cell
seed
plate
h
transfect
mention
plasmid
renilla
luciferas
report
plasmid
intern
control
use
lipofectamin
reagent
invitrogen
h
cell
wash
phosphat
buffer
salin
pb
infect
iav
multipl
infect
moi
adsorpt
h
cell
wash
time
pb
grown
drugcontain
viru
growth
medium
vgm
mem
tpcktrypsin
wv
bovin
serum
albumin
incub
h
luciferas
activ
determin
follow
instrument
luciferas
report
assay
kit
bd
bioscienc
clontech
result
present
fold
chang
normal
renilla
luciferas
activ
dmso
use
group
dissolv
drug
viral
titer
determin
plaqu
format
assay
previous
report
plaqu
inhibit
assay
also
perform
previous
report
briefli
cell
infect
iav
moi
meanwhil
treat
without
differ
concentr
omt
h
adsorpt
wash
pb
time
vgm
medium
without
omt
ad
h
cell
lyse
freez
thaw
centrifug
g
min
supernat
collect
viral
titer
determin
plaqu
format
assay
timeofaddit
assay
contain
four
test
perform
previous
report
direct
inactiv
assay
infect
iav
viru
incub
vgm
medium
contain
omt
h
iav
virion
gather
ultrafiltr
wash
pb
time
use
infect
mdck
cell
cultur
h
b
influenceoncel
assay
infect
mdck
cell
incub
vgm
medium
contain
omt
h
cell
wash
pb
time
infect
normal
iav
cultur
h
c
influenceonviraladsorpt
assay
viral
adsorpt
h
omt
ad
adsorpt
cell
wash
pb
time
cultur
normal
vgm
medium
h
differenttimepoint
post
infect
pi
assay
iav
infect
omt
ad
h
pi
respect
cultur
h
pi
moi
dmso
use
neg
control
nc
h
cell
lysat
gather
viral
titer
determin
plaqu
format
assay
stock
solut
iav
first
serial
dilut
vgm
medium
mdck
cell
seed
plate
h
infect
iav
h
calcul
follow
method
reed
muench
antivir
activ
also
evalu
srb
method
briefli
mdck
cell
seed
plate
ml
viru
suspens
ml
medium
contain
test
drug
ad
h
wash
aceton
ad
remov
aceton
plate
dri
ad
wv
srb
wash
plate
dri
ad
mm
trisbas
solut
od
read
nm
three
well
use
neg
virusinfect
nondrugtr
mock
control
noninfect
nondrugtr
dmso
use
group
percent
protect
omt
posit
relat
cell
viabil
calcul
follow
protect
test
compound
concentr
protect
defin
antivir
index
ai
calcul
cell
viabil
neg
control
express
percent
mock
group
quantit
rtpcr
qrtpcr
assay
carri
previou
report
briefli
total
rna
extract
use
plu
rna
purif
kit
invitrogen
dna
contamin
remov
ad
dnase
invitrogen
total
rna
quantifi
spectrophotometr
nm
firststrand
cdna
synthes
use
superscript
iii
revers
transcriptas
kit
invitrogen
realtim
pcr
reaction
mixtur
contain
cdna
nm
primer
sybr
green
master
mix
invitrogen
result
express
primer
present
tabl
western
blot
perform
previous
report
protein
prepar
use
ripa
lysi
buffer
shanghai
shenergi
biocolor
bioscienc
technolog
shanghai
china
detect
nuclear
transloc
nucleic
protein
extract
use
epiquik
nuclear
extract
kit
epigentek
wuhan
china
protein
concentr
determin
bca
assay
thermofish
scientif
rockford
il
usa
use
invari
control
total
protein
lamin
use
control
nuclear
protein
result
analyz
imagej
softwar
cell
cultur
lung
tissu
collect
frozen
cytokin
mmp
quantifi
specif
elisa
kit
elisa
kit
purchas
dakew
biolog
technolog
co
ltd
beij
china
elisa
kit
purchas
abcam
compani
cambridg
uk
anim
experi
perform
accord
arriv
guidelin
experiment
procedur
approv
institut
anim
care
use
committe
iacuc
shantou
univers
author
number
march
male
femal
mice
g
week
specifi
pathogen
free
spf
purchas
shanghai
slack
laboratori
anim
co
ltd
shanghai
china
anim
hous
spf
facil
contain
standard
bed
lightdark
cycl
h
temperatur
humid
control
ventil
fed
standard
irradi
pellet
food
steril
water
ad
libitum
experi
mice
fed
day
acclim
preliminari
test
twenti
mice
use
determin
mous
lethal
dose
method
reed
muench
determin
test
dose
omt
also
refer
previou
report
experi
mice
randomli
divid
group
use
random
number
tabl
anesthet
intraperiton
inject
ketamin
mgkg
effort
made
minim
suffer
dmso
vv
oseltamivir
omt
given
twice
day
interv
day
start
h
randomli
group
viru
exposur
bodi
weight
symptom
surviv
ten
mice
group
n
monitor
daili
day
viru
inocul
day
pi
anoth
six
mice
group
n
euthan
cervic
disloc
lung
index
assess
determin
percent
lung
wet
weight
g
bodi
weight
g
lung
index
lung
wet
weight
g
bodi
weight
g
collect
lung
separ
two
set
right
lung
fix
formalin
left
lung
frozen
left
lung
homogen
ml
cold
mem
medium
total
protein
level
measur
use
biorad
protein
assay
kit
viral
titer
target
protein
determin
elisa
qrtpcr
assay
unit
correct
amount
protein
examin
patholog
chang
right
side
lung
embed
paraffin
section
haematoxylin
eosin
h
e
stain
sever
histolog
chang
score
accord
semiquantit
score
system
show
supplement
materi
method
statist
signific
comparison
treat
group
assess
student
ttest
oneway
anova
post
hoc
dunnett
test
kaplanmei
analysi
logrank
breslow
test
use
softwar
valu
express
mean
standard
deviat
sd
p
valu
consid
statist
signific
omt
decreas
iavinduc
express
phosphoryl
mapk
nuclear
transloc
mapk
activ
antagon
antiiav
activ
omt
specul
antiiav
activ
omt
may
relat
abil
inhibit
iavinduc
activ
mapk
pathway
figur
final
base
result
studi
peopl
research
think
omt
promis
drug
treat
iav
infect
iavinduc
pneumonia
